Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00452842 · ClinicalTrials.gov registry record
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 26,784
- Enrollment target
NCT00452842: Clinical Trial study, sponsored by Pfizer.
NCT00452842 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 26,784 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00452842 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 26,784 participants
- Enrollment target
Study Summary
An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,784 participants |
| Start Date | 2007-10 |
Why NCT00452842 stopped before completion
NCT00452842 is an observational study that tracks outcomes without assigning an intervention. Its 26,784 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00452842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00452842 about?
NCT00452842 is a clinical study titled "Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies". An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.
What is the current status of trial NCT00452842?
This trial is currently terminated. The enrollment target is 26,784 participants. The study started on 2007-10.
Who is sponsoring clinical trial NCT00452842?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia